Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "Notably , the current recommended drugs for the treatment of severe COVID-19 , dexamethasone and remdesivir ," provenance.
- SUBJECT label "physicians" assertion.
- SUBJECT label "dexamethasone and heparin 's possible efficacy in viral pneumonia" provenance.
- SUBJECT label "dexamethasone and heparin 's possible efficacy in viral pneumonia" provenance.
- SUBJECT label "dexamethasone and heparin 's possible efficacy in viral pneumonia" provenance.
- SUBJECT label "dexamethasone and heparin 's possible efficacy in viral pneumonia" provenance.
- SUBJECT label "dexamethasone and heparin 's possible efficacy in viral pneumonia" provenance.
- SUBJECT label "remdesivir for both 5 and 10 days , lopinavir / ritonavir , and dexamethasone" provenance.
- SUBJECT label "remdesivir for both 5 and 10 days , lopinavir / ritonavir , and dexamethasone" provenance.
- SUBJECT label "remdesivir for both 5 and 10 days , lopinavir / ritonavir , and dexamethasone" provenance.
- SUBJECT label "remdesivir for both 5 and 10 days , lopinavir / ritonavir , and dexamethasone" provenance.
- SUBJECT label "remdesivir for both 5 and 10 days , lopinavir / ritonavir , and dexamethasone" provenance.
- SUBJECT label "remdesivir for both 5 and 10 days , lopinavir / ritonavir , and dexamethasone" provenance.
- SUBJECT label "remdesivir for both 5 and 10 days , lopinavir / ritonavir , and dexamethasone" provenance.
- SUBJECT label "remdesivir for both 5 and 10 days , lopinavir / ritonavir , and dexamethasone" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "dexamethasone ( Dex )" provenance.
- SUBJECT label "adjunctive treatment of established ARDS caused by the coronavirus disease 2019 ( COVID)-19 ) with intravenous dexamethasone" provenance.
- SUBJECT label "adjunctive treatment of established ARDS caused by the coronavirus disease 2019 ( COVID)-19 ) with intravenous dexamethasone" provenance.
- SUBJECT label "adjunctive treatment of established ARDS caused by the coronavirus disease 2019 ( COVID)-19 ) with intravenous dexamethasone" provenance.